Company XSPY PHAR Nasdaq Stockholm
Equities
SE0009973563
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Per Andersson
CEO | Chief Executive Officer | 57 | 06-08-31 |
Director of Finance/CFO | 52 | Feb. 07 | |
Thomas Walz
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Chief Tech/Sci/R&D Officer | 60 | 17-12-31 | |
Investor Relations Contact | 63 | 19-05-14 | |
Sales & Marketing | - | 22-03-14 | |
Andreas Konar
PRN | Corporate Officer/Principal | 75 | 09-12-31 |
Edward Jordan
PRN | Corporate Officer/Principal | 55 | 23-09-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 14-12-31 | |
Carl-Johan Spak
BRD | Director/Board Member | 68 | 14-12-31 |
Chairman | 70 | 22-05-18 | |
Director/Board Member | 55 | 16-12-31 | |
Christine Lind
BRD | Director/Board Member | 50 | 18-12-31 |
Director/Board Member | 66 | 20-12-31 | |
Robert Molander
BRD | Director/Board Member | 59 | 22-05-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,253,542 | 18,510,319 ( 59.23 %) | 0 | 59.23 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.67% | 12.27B |